ArticleNature communications2026
Chemodivergent Coupling of 1,3-Enynes with Anilines to Access Dihydropyrrole Skeleton under Palladium Catalysis.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
2,5-Dihydropyrroles are prevalent structural motifs in various natural products and biologically active molecules. Conventional methods for constructing these heterocycles often rely on elaborate multi-step procedures or complex starting materials. Herein, we describe a palladium-catalyzed chemodivergent protocol for synthesizing functionalized 2,5-dihydropyrrole scaffolds from readily accessible 1,3-enynes and anilines. By modulating the relative rates of the selectivity-determining steps, either two-component annulation or three-component telomerization can be selectively achieved, affording two distinct types of functionalized 2,5-dihydropyrroles in excellent yields and with high selectivities. Mechanistic studies reveal that the reaction initially proceeds through 1,4-hydroamination of 1,3-enynes to generate an aminomethyl allene intermediate, followed by an intramolecular annulation affording 2-substituted 2,5-dihydropyrroles. This process is significantly accelerated in the presence of Pd(II) catalysts. However, employing Pd(0) precursors, strong acids, and excess ligand effectively decelerates this pathway, diverting the selectivity towards reaction with a second equivalent of 1,3-enyne to yield the telomeric products. This study not only provides an atom-economical method for constructing the 2,5-dihydropyrrole core but also offers a valuable strategy for the development of telomerization chemistry.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.